News | Oncomark

November 2015 - OncoMasTR in Business&Finance

OncoMark profiled in 'Ones to Watch' article in Business & Finance

The Business & Finance magazine interviewed OncoMark's CEO, Mr Desmond O'Leary, to discuss the development of the OncoMasTR assay for early stage breast cancer.

November 2015 - OncoMark in the Sunday Times

OncoMark featured in The Sunday Times

Read about our CEO's experience in the diagnostics industry and his selection of OncoMark as his new venture in the Sunday Times.

September 2015 - €2.7 million awarded by the EC

OncoMark are awarded €2.7 million by the European Commission to develop a diagnostic assay for breast cancer

OncoMark are pleased to announce they have been awarded €2.7 million by the European Commission, for the commercial development of a new Diagnostic test for breast cancer patients. This award will fund the development and commercialisation of OncoMasTR, a novel prognostic assay for early stage breast cancer that will reduce the number of breast cancer patients receiving unnecessary chemotherapy.

August 2015 - New OncoMark CEO

Mr Desmond O'Leary joins OncoMark as Chief Executive

We are pleased to announce the appointment of Mr Desmond O Leary to the position of Chief Executive Officer of OncoMark. Mr O Leary is an experienced executive with over 20 years in the diagnostic industry.

December 2014 - Medical Lab of the Year

OncoMark wins Medical Laboratory of the Year at 2014 Irish Laboratory Awards

CEO of OncoMark, Dr Máirín Rafferty collects the award for Medical Laboratory of the Year at this year's Irish Laboratory Awards held in Dublin on Wednesday, 3rd December 2014.

Joe Barry, Managing Director of Lennox presents the award.